Literature DB >> 17192541

Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta.

Aileen M Barnes1, Weizhong Chang, Roy Morello, Wayne A Cabral, MaryAnn Weis, David R Eyre, Sergey Leikin, Elena Makareeva, Natalia Kuznetsova, Thomas E Uveges, Aarthi Ashok, Armando W Flor, John J Mulvihill, Patrick L Wilson, Usha T Sundaram, Brendan Lee, Joan C Marini.   

Abstract

Classic osteogenesis imperfecta, an autosomal dominant disorder associated with osteoporosis and bone fragility, is caused by mutations in the genes for type I collagen. A recessive form of the disorder has long been suspected. Since the loss of cartilage-associated protein (CRTAP), which is required for post-translational prolyl 3-hydroxylation of collagen, causes severe osteoporosis in mice, we investigated whether CRTAP deficiency is associated with recessive osteogenesis imperfecta. Three of 10 children with lethal or severe osteogenesis imperfecta, who did not have a primary collagen defect yet had excess post-translational modification of collagen, were found to have a recessive condition resulting in CRTAP deficiency, suggesting that prolyl 3-hydroxylation of type I collagen is important for bone formation. Copyright 2006 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192541      PMCID: PMC7509984          DOI: 10.1056/NEJMoa063804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Prolyl 3-hydroxylase: partial characterization of the enzyme from rat kidney cortex.

Authors:  J Risteli; K Tryggvason; K I Kivirikko
Journal:  Eur J Biochem       Date:  1977-03-01

2.  Homozygous osteogenesis imperfecta unlinked to collagen I genes.

Authors:  K Aitchison; D Ogilvie; M Honeyman; E Thompson; B Sykes
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

3.  Formation of the triple helix of type I procollagen in cellulo. Temperature-dependent kinetics support a model based on cis in equilibrium trans isomerization of peptide bonds.

Authors:  P Bruckner; E F Eikenberry
Journal:  Eur J Biochem       Date:  1984-04-16

4.  Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.

Authors:  Francis H Glorieux; Leanne M Ward; Frank Rauch; Ljiljana Lalic; Peter J Roughley; Rose Travers
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

Review 5.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

6.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

7.  Osteogenesis imperfecta type VII maps to the short arm of chromosome 3.

Authors:  M Labuda; J Morissette; L M Ward; F Rauch; L Lalic; P J Roughley; F H Glorieux
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

8.  Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.

Authors:  L M Ward; F Rauch; R Travers; G Chabot; E M Azouz; L Lalic; P J Roughley; F H Glorieux
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

9.  Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.

Authors:  M Raghunath; P Bruckner; B Steinmann
Journal:  J Mol Biol       Date:  1994-02-25       Impact factor: 5.469

10.  cDNA cloning, characterization and chromosome mapping of Crtap encoding the mouse cartilage associated protein.

Authors:  R Morello; L Tonachini; M Monticone; L Viggiano; M Rocchi; R Cancedda; P Castagnola
Journal:  Matrix Biol       Date:  1999-06       Impact factor: 11.583

View more
  113 in total

1.  Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.

Authors:  M Valli; A M Barnes; A Gallanti; W A Cabral; S Viglio; M A Weis; E Makareeva; D Eyre; S Leikin; F Antoniazzi; J C Marini; M Mottes
Journal:  Clin Genet       Date:  2011-10-19       Impact factor: 4.438

2.  Immortalized Mouse Floxed Fam20c Dental Papillar Mesenchymal and Osteoblast Cell Lines Retain Their Primary Characteristics.

Authors:  Chao Liu; Xiaofang Wang; Hua Zhang; Xiaohua Xie; Peihong Liu; Ying Liu; Priyam H Jani; Yongbo Lu; Shuo Chen; Chunlin Qin
Journal:  J Cell Physiol       Date:  2015-11       Impact factor: 6.384

Review 3.  Chaperoning osteogenesis: new protein-folding disease paradigms.

Authors:  Elena Makareeva; Nydea A Aviles; Sergey Leikin
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

4.  Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.

Authors:  Shawna M Pyott; Ulrike Schwarze; Helena E Christiansen; Melanie G Pepin; Dru F Leistritz; Richard Dineen; Catharine Harris; Barbara K Burton; Brad Angle; Katherine Kim; Michael D Sussman; Maryann Weis; David R Eyre; David W Russell; Kevin J McCarthy; Robert D Steiner; Peter H Byers
Journal:  Hum Mol Genet       Date:  2011-01-31       Impact factor: 6.150

Review 5.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

6.  COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.

Authors:  Aileen M Barnes; Aarthi Ashok; Elena N Makareeva; Marina Brusel; Wayne A Cabral; MaryAnn Weis; Catherine Moali; Emmanuel Bettler; David R Eyre; John P Cassella; Sergey Leikin; David J S Hulmes; Efrat Kessler; Joan C Marini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

Review 7.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

8.  WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.

Authors:  Shawna M Pyott; Thao T Tran; Dru F Leistritz; Melanie G Pepin; Nancy J Mendelsohn; Renee T Temme; Bridget A Fernandez; Solaf M Elsayed; Ezzat Elsobky; Ishwar Verma; Sreelata Nair; Emily H Turner; Joshua D Smith; Gail P Jarvik; Peter H Byers
Journal:  Am J Hum Genet       Date:  2013-03-14       Impact factor: 11.025

9.  CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.

Authors:  Dustin Baldridge; Ulrike Schwarze; Roy Morello; Jennifer Lennington; Terry K Bertin; James M Pace; Melanie G Pepin; Maryann Weis; David R Eyre; Jennifer Walsh; Deborah Lambert; Andrew Green; Haynes Robinson; Melonie Michelson; Gunnar Houge; Carl Lindman; Judith Martin; Jewell Ward; Emmanuelle Lemyre; John J Mitchell; Deborah Krakow; David L Rimoin; Daniel H Cohn; Peter H Byers; Brendan Lee
Journal:  Hum Mutat       Date:  2008-12       Impact factor: 4.878

10.  Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.

Authors:  Aileen M Barnes; Erin M Carter; Wayne A Cabral; MaryAnn Weis; Weizhong Chang; Elena Makareeva; Sergey Leikin; Charles N Rotimi; David R Eyre; Cathleen L Raggio; Joan C Marini
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.